Revolutionizing Healthcare: Metyos Secures $2.3M in Seed Funding for Innovative Wearable Patch Solution

We are thrilled to announce that Metyos has successfully raised $2.3 million in funding to accelerate our mission of transforming chronic disease management and enhancing patient care. At Metyos, we are dedicated to helping individuals lead healthier, longer lives by preventing chronic diseases and improving patient-doctor interactions through innovative technology. Our cutting-edge solution, which includes a sophisticated wearable patch that provides real-time measurements of molecular biomarkers, empowers patients to take control of their health through a user-friendly smartphone app. This not only allows for efficient self-monitoring but also facilitates seamless communication between patients and their doctors via our remote patient monitoring platform. This innovative approach enables healthcare providers to swiftly address urgent situations as they arise while ensuring comprehensive long-term follow-up for each patient. The recent funding will be instrumental in expanding our research and development efforts, enhancing our technology, and ultimately scaling our operations to reach more patients and healthcare professionals. We believe that timely and effective management of chronic diseases can significantly improve health outcomes, and with this financial boost, Metyos is poised to set new standards in healthcare. As we look forward to the next phase of growth, we remain committed to our vision of a world where every individual has the tools necessary for proactive health management and meaningful engagement with their healthcare providers. Thank you for being a part of our journey!